Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    21410393 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Condition: Pulmonary Lymphangioleiomyomatosis
Intervention: Drug: saracatinib
2 Recruiting Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
Conditions: Tuberous Sclerosis;   Lymphangioleiomyomatosis;   Angiomyolipoma
Intervention:
3 Completed Rapalogues for Autism Phenotype in TSC: A Feasibility Study
Conditions: Tuberous Sclerosis Complex;   Self-injury;   Autism
Interventions: Drug: Sirolimus;   Drug: Everolimus
4 Unknown  Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
Condition: Lymphangioleiomyomatosis
Interventions: Drug: Sirolimus;   Drug: Placebo sirolimus

Indicates status has not been verified in more than two years